| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.04 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.043 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |